Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11445429 | 1.00 | LMNA (0.55) | LMNABLMTSHRCYP1A2MAPK1 | |
| SCHEMBL24196133 | 0.82 | TSHR (0.50) | LMNATSHR | |
| SCHEMBL24667370 | 0.82 | TSHR (0.50) | LMNATSHR | |
| SCHEMBL4202851 | 0.80 | — | — | |
| SCHEMBL4202857 | 0.80 | — | — | |
| SCHEMBL7950449 | 0.78 | TSHR (0.46) | LMNATSHR | |
| SCHEMBL10536981 | 0.78 | LMNA (0.59) | LMNABLMTSHRCYP1A2MAPK1 | |
| SCHEMBL1345692 | 0.78 | — | — | |
| SCHEMBL2575431 | 0.76 | TSHR (0.44) | LMNATSHR | |
| SCHEMBL10526307 | 0.76 | TSHR (0.44) | LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-4549617-A1 | PREPARATION OF SATURATED OR ETHYLENICALLY UNSATURATED (CYCLO)ALIPHATIC COMPOUNDS BY HYDROGENATION OF ETHYLENICALLY OR ACETYLENICALLY UNSATURATED (CYCLO)ALIPHATIC COMPOUNDS USING HYDROGEN WITH LOW DEUTERIUM CONTENT | BASF SE (DE) | 2025-05-07 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| EP-2555742-B2 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2556139-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-08-02 | — | — | EP | claimed |
| EP-2555742-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-03-16 | — | — | EP | claimed |
| US-9023783-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2015-05-05 | — | — | US | claimed |
| US-20140342969-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2014-11-20 | — | — | US | claimed |
| US-20100204083-A1 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2010-08-12 | — | — | US | claimed |
| EP-1868988-B1 | METHOD FOR PRODUCING SATURATED NITRILES | BASF SE (DE) | 2008-10-08 | — | — | EP | claimed |
| US-20080177100-A1 | Method For Producing Saturated Nitriles | BASF AKTIENGEELLSCHAFT (DE) | 2008-07-24 | — | — | US | claimed |
| US-7399318-B2 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-15 | — | — | US | claimed |
| EP-1868988-A1 | METHOD FOR PRODUCING SATURATED NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-26 | — | — | EP | claimed |
| EP-1714637-A2 | Stable composition for hair dye comprising a fragrance | Takasago International Corporation (JP) | 2006-10-25 | — | — | EP | claimed |
| WO-2006106141-A1 | METHOD FOR PRODUCING SATURATED NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-12 | — | — | WO | claimed |
| US-20060218730-A1 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-10-05 | — | — | US | claimed |
| EP-0622451-B1 | Perfumed hypochlorite bleaching compositions | PROCTER & GAMBLE (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0867503-A2 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1998-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204083-A1 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | CYP51A1, ESD, CYP3A4 | LMNA 1837/4885BLM 4625/4885TSHR 4784/4885 |
| US-20080177100-A1 | Method For Producing Saturated Nitriles | GGPS1, NOS2, NOS1 | LMNA 2597/4885BLM 4452/4885TSHR 4711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.